Last reviewed · How we verify

Ropivacaine irrigation — Competitive Intelligence Brief

Ropivacaine irrigation (Ropivacaine irrigation) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesiology.

phase 3 Local anesthetic Voltage-gated sodium channels Anesthesiology Small molecule Live · refreshed every 30 min

Target snapshot

Ropivacaine irrigation (Ropivacaine irrigation) — Hospital General Universitario Elche. Ropivacaine is a local anesthetic that works by blocking sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ropivacaine irrigation TARGET Ropivacaine irrigation Hospital General Universitario Elche phase 3 Local anesthetic Voltage-gated sodium channels
Control (bupivacaine) Control (bupivacaine) Kasr El Aini Hospital marketed Local anesthetic (amide) Voltage-gated sodium channels
Lidocaine (drug) Lidocaine (drug) Daniel A Tonetti, MD marketed Local anesthetic Voltage-gated sodium channels
Hyperbaric bupivacaine+Morphine Hyperbaric bupivacaine+Morphine Fundación Pública Andaluza Progreso y Salud marketed Local anesthetic + opioid combination Voltage-gated sodium channels (bupivacaine); mu opioid receptors (morphine)
Bupivacaine (Marcaine) Bupivacaine (Marcaine) NYU Langone Health marketed Local anesthetic (amide) Voltage-gated sodium channels
lamotrigine (generic Teva) lamotrigine (generic Teva) University of Maryland, Baltimore marketed Anticonvulsant / Mood stabilizer Voltage-gated sodium channels; glutamate release inhibition
Lidocaine solution ("A") Lidocaine solution ("A") Hospital Universitari de Bellvitge marketed Local anesthetic Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ropivacaine irrigation — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-irrigation. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: